Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing weight fast on Mounjaro comes down to working with the medicine, not waiting for it to do everything. Tirzepatide reduces appetite significantly, but the people who see the strongest results pair it with consistent protein intake, movement, and enough sleep to let the medicine do its job. Mounjaro (tirzepatide) is a prescription-only medicine, and a prescriber assesses whether it is right for you before treatment starts. What follows is a factual look at the factors within your control once you are on it — drawn from clinical evidence and NHS guidance on tirzepatide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Both, and it helps to understand the distinction. Tirzepatide targets the GIP and GLP-1 receptors simultaneously, which slows how quickly your stomach empties and signals fullness to your brain well before a plate is empty. This is a physiological change, not a mood or motivation shift. You are likely to eat less simply because the drive to eat is quieter. That mechanism is explained clearly in NICE's appraisal of tirzepatide (TA1026).
Where people sometimes feel let down is expecting the medicine to do it all passively. Tirzepatide creates the conditions for faster weight loss; your habits determine how far those conditions take you. In SURMOUNT-1, participants also followed a reduced-calorie diet and increased their physical activity, the trial was designed that way, and so is the medicine's UK licence. Results without those elements are typically slower. That is not a criticism; it is just the clinical reality.
If you want to understand the mechanism in more depth before or during treatment, our page on how Mounjaro works to lose weight goes through the dual-receptor process step by step.
Appetite suppression is powerful enough that some people on tirzepatide eat far too little, skipping meals entirely. That feels efficient in the short term. Over weeks, though, it tends to cost muscle mass rather than fat, and muscle is metabolically active tissue you want to keep. Rapid fat loss is more sustainable when protein intake stays adequate, roughly 1.2–1.6g per kilogram of body weight daily is a frequently cited clinical target, though your prescriber or a dietitian can personalise that figure.
Practically, this often means building meals around a protein source first (eggs, chicken, fish, legumes, Greek yoghurt) and then letting appetite guide the rest. Fibre-rich vegetables help with the gastrointestinal side effects that some people notice in the early weeks, particularly constipation. Hydration matters more than it sounds: nausea is a common early experience, and being even mildly dehydrated makes it worse.
A reduced-calorie approach does not have to mean counting every gram. Many people find that Mounjaro naturally brings their portion sizes down to where a modest deficit happens without deliberate restriction. The goal is to support that process rather than fight it. If you are thinking about how to push results further on Mounjaro, eating habits are consistently where the biggest gains are made.
Yes, and the effect is meaningful. Physical activity increases energy expenditure, which deepens the calorie deficit the medicine creates. Resistance training specifically helps preserve lean muscle while fat is being lost, relevant on any significant weight-loss programme, and particularly so when appetite is reduced enough that total calories are lower than usual.
You do not need an intense regime from day one. Walking more than you currently do is genuinely useful. A 30-minute walk most days is enough to meaningfully support the medicine's effect. If you can add two or three sessions of resistance work each week, the combination tends to produce noticeably better body composition than cardio alone.
Timing exercise away from the period just after an injection can help if you find that nausea peaks in the first 24 hours. Many people on tirzepatide inject in the evening to sleep through the worst of any early discomfort, and our page on how to lose weight faster on Mounjaro covers timing, activity, and other practical adjustments worth considering. For a broader look at lifestyle factors alongside treatment, the guide to losing weight on Mounjaro covers the full picture.
In clinical trials, meaningful weight loss started within the first few weeks for most participants, with the rate accelerating as the dose increased over the titration schedule. Real-world progress varies: some people lose steadily from the first pen; others find the early doses feel slow, with results picking up significantly from 7.5mg or 10mg onwards. Neither pattern is unusual.
A plateau after several months on a stable dose is not always a signal that something has gone wrong. Bodies adapt. Your prescriber may discuss a dose increase, a dietary review, or simply reassurance that slower progress mid-treatment is normal before it picks back up. Trying to accelerate things by skipping the titration schedule is counterproductive, the gradual ramp-up exists to reduce nausea and protect tolerability.
If you are comparing the pace of your progress against others or against published averages, it is worth remembering those averages include a very wide range of individual responses. A question our prescribers hear regularly is whether something is going wrong when it is simply going differently. If anything concerns you, early contact with your clinical team is always the right call rather than adjusting anything independently. You can read more about treatment at the tirzepatide overview, or if cost is a factor in your thinking, the Mounjaro pricing page sets out what private treatment typically involves. When you are ready to speak to a prescriber, starting a free consultation with our clinical team is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.